MedTrace Logo

Bioavailability Study of Cinnamon in Healthy Subjects

NCT01847053 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-03-06

No results posted yet for this study

Summary

A partial double-blind, randomized, placebo-controlled, 4-treatment crossover study design will be used to evaluate bioavailability of various forms of cinnamon and to determine the effects of 3 and 6 g of cinnamon added to instant oatmeal on blood glucose levels in 8 healthy subjects. In the extended dose response study, three subjects will continue the study and be offered 5 day consecutive feedings of 9 g cinnamon extract and on Day 6, and blood samples would be collected over 6 hours after a single morning dose. Urinary samples would be collected upon to 48 hours.

Conditions

  • Healthy Males

Interventions

OTHER

cinnamon

Intervention will be both ground cinnamon and cinnamon extract.

OTHER

Oatmeal

Oatmeal control, around 70g; without cinnamon

Sponsors & Collaborators

  • Appalachian State University

    collaborator OTHER

  • McCormick and Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Kevin Maki, PhD · Biofortis Clinical Research, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-12-31
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01847053 on ClinicalTrials.gov